Joseph T. Brozinick
Eli Lilly and Company
Lilly Corporate Center
Indianapolis
IN 46285
USA
Name/email consistency: high
- "Actin"g on GLUT4: membrane & cytoskeletal components of insulin action. Brozinick, J.T., Berkemeier, B.A., Elmendorf, J.S. Curr. Diabetes. Rev (2007)
- Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeleton in glucose transporter 4 translocation in insulin-sensitive tissues. Brozinick, J.T., Hawkins, E.D., Strawbridge, A.B., Elmendorf, J.S. J. Biol. Chem. (2004)
- Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance. Brozinick, J.T., Roberts, B.R., Dohm, G.L. Diabetes (2003)
- 1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle. Brozinick, J.T., Reynolds, T.H., Dean, D., Cartee, G., Cushman, S.W. Biochem. J. (1999)
- Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. Brozinick, J.T., Birnbaum, M.J. J. Biol. Chem. (1998)